…a new wave of research is exploring the therapeutic uses of other substances such as magic mushrooms, MDMA and LSD, not just as party drugs but as real-life neurotechnologies that can act as a chemical nudge on the brain systems involved in love and attachment. …let’s not forget, love itself is also not to be taken lightly. Instead of…
…people are exploring alternative medicines to help them function and live happily in today’s fast-paced, tech-warped world. …people don’t like to drink anymore. People don’t like to be hungover. Alcohol is a toxin, so it does tend to be stressful for the body. We have other things to enjoy and alter our consciousness for fun…
…researchers have built a virtual library of 75 million compounds related to these drugs. This approach yielded two molecules that showed antidepressant properties in mice, but without the hallucinogenic activity of psychedelic drugs. Original Article (Nature):Virtual library of LSD-like drugs could reveal new antidepressantsArtwork Fair Use: Jimmy-neutron
When controlling for confounding variables, the results revealed that lifetime psychedelic use was not associated with lifetime cancer diagnosis nor hematologic cancer diagnosis. This was true for each of the three classifications of psychedelics: tryptamine (5-MeO-DIPT, AMT, DMT), lysergamide (LSD), and phenethylamine (2C-B, mescaline, MDMA, peyote, and San Pedro). “Beginning in the late 1960s, concerns were raised by laboratory experiments that…
The proposed quota for psilocybin is the same in 2023 as it was this year [2022], at 8,000 grams. But it’s looking to double the manufacturing of the other key ingredient in so-called magic mushrooms, psilocyn [ie, psilocin], from 4,000 to 8,000 grams. For LSD, the agency’s 2023 quota is 1,200 grams, almost triple the…
The problem is that in the real world… people with characteristics that would have excluded them from the psilocybin trial are common… exclusion criteria are not the only problematic aspect… of psychedelics, however. Another is the psychotherapeutic component of the treatment, which is currently variable, time-consuming and extensive. In the psilocybin trial mentioned… two therapists…
…LSD and psilocybin activate serotonin receptors on brain cells in a way that reduces the energy needed for the brain to switch between different activity states, according to a study led by Weill Cornell Medicine researchers… “Serotonin 2a receptors have a spatial distribution in the brain that appears to be optimized for lowering these state…
When pressed on why the police nor the city have moved to shut the business down – let alone make any arrests – representatives of both have expressed that they’re more concerned with addressing the opioid crisis rather than wrestling with the increasingly embraced psychedelic scene. It probably isn’t a stretch to guess that they…
…published in the journal Biological Psychiatry, a team of Swiss researchers administered 20 participants, who were diagnosed with a life-threatening illness, and a further 22 participants with a mental disorder, significant amounts of lysergic acid diethylamide (LSD)… Participants of the study received either LSD or a placebo over three visits covering a 24-week period. The ones who…
The study, which appears in the Journal of Humanistic Psychology, provides evidence that this is the case for both clinical and non-clinical populations… the participants answered questions regarding their integration practices in the wake of their psychedelic experiences. In other words, they reported the extent to which they intentionally revisited aspects their psychedelic experiences, incorporated…
Recent Comments